NSBN Firm Video

NSBN Video watch

Media Contact

Tammy Mescobi,
Director of Media &
Public Relations tam@nsbn.com
310.288.4283

Our partners are available to provide information and commentary for media interviews and articles.

NSBN Speaker Series Featuring Tom Sherak

May 22, 2008

NSBN LLP (www.nsbn.com), Certified Public Accountants and Business Consultants in Beverly Hills will be hosting a luncheon on Thursday, May 22, 2008. The featured speaker will be Tom Sherak who will speak on the state of the entertainment industry. In line with past speaker series events hosted by NSBN LLP which have covered both Economic & Health issues, Tom Sherak has invited Dr. John Mazziotta and Dr. Rhonda Voskuhl to speak about the latest on the fight against Multiple Sclerosis (MS) due to Sherak's involvement with various MS nonprofit organizations. "Hosting this event is one of many ways NSBN gives back to the community" says Ken Miles, NSBN LLP Managing Partner.

Tom Sherak has been a partner at Revolution Studios, Chairman of Twentieth Century Fox Domestic Film Group, and Senior Executive Vice President of both Fox Film Entertainment and Twentieth Century Fox. Sherak is an active board member of the Southern California Multiple Sclerosis Society, Fulfillment Fund of Southern California, Southern California Variety - the Children's Charity, and a former Chairman of the Will Rogers Motion Picture Pioneers Foundation. 

Dr. John Mazziotta has had a leadership role in describing what has now become our understanding of the disruption of normal functional brain networks in a wide range of neurological disorders.  Dr. Mazziotta established the first Brain Mapping Center at UCLA that included methods available to study human brain structure and function.  He is now the Chair of one of the largest neurology departments in the United States. 

Rhonda Voskuhl, MD is the Director of UCLA Multiple Sclerosis Program and Professor of Neurology.  She has studied the effect of sex hormones and sex chromosomes on both inflammation and neurodegeneration. Dr. Voskuhl's research focus is to make basic discoveries at the research bench and to move them to novel therapies at the bedside, a prototypic example of translational research.